SAGE Therapeutics Options Traders Don't Buy Depression Drug Breakout

SAGE Therapeutics Options Traders Don't Buy Depression Drug Breakout”

Today's results are important to consider, of course, but for bright investors, it's the future that matters, and the future of SAGE Therapeutics Inc (NASDAQ:SAGE) looks bright.

1,102 are owned by Quantbot Tech Limited Partnership. Northern holds 0.01% or 411,444 shares. Dupont Cap accumulated 13,528 shares. Airain Ltd holds 0.06% or 17,281 shares in its portfolio. (NASDAQ:SAGE). Nicholas Prtn L P invested 0.43% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Tocqueville Asset Mngmt Lp holds 71,450 shares or 0.07% of its portfolio. State Common Retirement Fund reported 0% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Nebraska-based Cwm Limited Liability Co has invested 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 67,872 shares. 1,000 were accumulated by Highlander Capital Mgmt Ltd Liability. Qs Investors Limited Liability Company holds 800 shares or 0% of its portfolio.

Deutsche Savings Bank Ag reported 660,413 shares. Citigroup has 0% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) hit a new 52-week high and has $165.55 target or 3.00 % above today's $160.73 share price. Leerink Swann's target price suggests a potential upside of 167.68% from the company's current price. An all time high points to a stock which has the most positive fundamentals ever.

Tightening the gaze, stock performance for the last 5 trading days is -2.39%. 570,600 shares of the company's stock were exchanged, compared to its average volume of 548,792. It has outperformed by 99.75% the S&P500. The company's quarterly revenue was up.0% compared to the same quarter last year. analysts forecast that Sage Therapeutics will post -7.4 earnings per share for the current fiscal year.

SAGE has been the subject of several other research reports. Canaccord Genuity set a $110.00 price target on SAGE Therapeutics and gave the stock a buy rating in a report on Thursday, February 23rd. Therefore 88% are positive. BlackRock Institutional Trust Company N.A. increased its stake in SAGE Therapeutics by 38.7% in the third quarter. From the opening price, the stock has seen a change of -0.40% recently clocking in with a price of $160.54. SAGE Therapeutics had 45 analyst reports since September 3, 2015 according to SRatingsIntel. As per Wednesday, March 30, the company rating was initiated by Goldman Sachs. BMO Capital Markets reissued an "outperform" rating and set a $112.00 price target (up previously from $85.67) on shares of Sage Therapeutics in a research report on Friday, November 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. Bank of America maintained it with "Buy" rating and $101 target in Thursday, November 16 report. The firm has "Buy" rating given on Thursday, November 2 by RBC Capital Markets. JP Morgan maintained the stock with "Buy" rating in Thursday, September 3 report. Raymond James upgraded Sage Therapeutics, Inc. Leerink Swann has "Buy" rating and $9700 target. (NASDAQ:SAGE) rating on Tuesday, June 20.

This is Sage's second success in as many months. Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 116.45% since December 7, 2016 and is uptrending. (NASDAQ:SAGE) were released by: and their article: "SAGE Therapeutics Options Traders Don't Buy Depression Drug Breakout" published on December 07, 2017 as well as's news article titled: "Mid-Day Market Update: Duluth Holdings Drops Following Q3 Results; SAGE ..." with publication date: December 07, 2017. The company engages in the development and commercialization of novel medicines to treat central nervous system disorders. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid that acts as a synaptic and extrasynaptic modulator of the Gamma-Amino Butyric Acid-A (GABAA) receptor.

Like this



08 December 2017
Time to Reconsider Aerovironment Incorporated (NASDAQ:AVAV) After Less Short Sellers?
Finally, Denver Investment Advisors LLC bought a new stake in shares of AeroVironment in the 2nd quarter valued at about $332,000. Announces Fiscal 2018 Second Quarter Results" published on December 05, 2017, published: " AeroVironment, Inc .

08 December 2017
Regal Entertainment Group (RGC) Upgraded to "Neutral" at Moffett Nathanson
The company reported $0.32 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.36 by $0.04. Shares of New York-listed Regal Entertainment (NYSE: RGC ) Have been downgraded by professional analysts at Macquarie.

08 December 2017
Australia name Mitchell Marsh in squad ahead of Perth Test
The all-rounder was ruled out of the tournament after suffering a shoulder injury and played a part in only two Tests. So he said to the selectors "you've made a good decision to take me up there".

08 December 2017
Poplar Forest Capital LLC Lifted Position in Signet Jewelers Limited (SIG)
Among 9 analysts covering Intersect ENT ( NASDAQ:XENT ), 6 have Buy rating, 0 Sell and 3 Hold. (NYSE:EMR) for 54,681 shares. RBC Capital Markets maintained Signet Jewelers Limited (NYSE:SIG) on Thursday, January 12 with "Outperform" rating.

08 December 2017
Peering into Recent Action from The Boston Beer Company, Inc. (NYSE:SAM)
Bluestein R H & Company increased Medtronic Plc (NYSE:MDT) stake by 18,764 shares to 318,231 valued at $28.24 million in 2017Q2. The rating was upgraded by Susquehanna on Monday, May 1 to "Positive". (NYSE: SAM ) latest ratings and price target changes.

08 December 2017
Apollo Commercial Real Estate Finance, Inc. (ARI) Consensus Earnings Outlook

08 December 2017
Israeli Military: Two Rockets Launched From Gaza Strip Did Not Reach Israel
President Donald Trump's announcement on Wednesday that he was recognising Jerusalem as Israel's capital . After the assault from Gaza, Israeli jets targeted military sites belonging to Hamas and Islamic Jihad.

08 December 2017
MSNBC reverses Sam Seder decision after intense backlash
The Seder-Cernovich dust-up was relatively trivial in itself but perhaps says something about the fraught politics of the moment. And Seder himself was clear that he felt MSNBC had made a mistake.

08 December 2017
Rockets fired into Israel near Gaza strip
Around two hours later the army said that another rocket, fired form the enclave's north, exploded in southern Israel. The army also fired several missiles and shells into Palestinian lands, in borer areas of the Gaza Strip.

08 December 2017
Michigan-Notre Dame 2018 season-opening game time announced
After a home game against Florida State on November 10, Notre Dame goes to NY to play Syracuse and visits USC on November 24. However, the Irish sacrificing a home game the week before Thanksgiving is a little bit of an unexpected development.